Champions Oncology (Champions), a developer of advanced technology solutions and services to personalize the development and use of oncology drugs, has signed a new discovery and drug development partnership with Teva Pharmaceutical ...
Tags: Champions Oncology
US-based specialty pharmaceutical firm Upsher-Smith Laboratories will launch the generic version of its Morphine Sulfate extended-release (ER) capsules, CII on 4 September 2013. Morphine Sulfate ER Capsules, CII are currently available in ...
Tags: ER Capsules, pharmaceutical
The European Commission has granted marketing authorization for Teva Pharmaceutical Industries' Lonquex (lipegfilgrastim) to commercialize in all twenty eight countries of the European Union plus Norway, Iceland and Liechtenstein. ...
Oncobiologics and inVentiv Health have formed a global, strategic partnership for clinical development of biosimilar assets initially with a probable expansion to new molecules. The biosimilar assets include generic versions of Humira, ...
Tags: Oncobiologics, Biosimilars
KU Leuven and FIT Biotech have reached a global license and partnership agreement for the development of novel immunotherapeutics leveraging FIT Biotech's gene transport unit (GTU) technology for transient in vivo expression of monoclonal ...
Pfizer's rheumatoid arthritis treatment, tofacitinib, has obtained approval in several additional countries globally, including Switzerland, Argentina, Kuwait, UAE and Russia for patients with inadequate response to current therapies. The ...
Aptiv Solutions, a US-based medical device and biopharmaceutical company, has introduced AptivInSite, a new adaptive monitoring methodology. Developed for medical device companies, AptivInSite helps in maximising trial efficiency while ...
Tags: Health, Medicine, biopharmaceutical
US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer. As per the deal, both the companies will advance the product ...
AOP Orphan Pharmaceuticals has announced the spin-off of its 80% stake in Activartis, a Vienna-based biotech company, to a group of private investors. Activartis has developed dendritic cell-based technology for individualized tumor ...
Tags: AOP Orphan, Medicine
Genmab and ADC Therapeutics have partnered to co-develop a new antibody-drug conjugate (ADC) product conjugate to treat multiple cancer indications. The collaboration will integrate Genmab's high-affinity fully human antibody targeting ...
Tags: Genmab, ADC Partner
Pfizer has collaborated with the University of California, San Francisco (UCSF) to expand its centers for therapeutic innovation (CTI) into the development of small-molecule drug candidates and enhance its drug discovery capabilities. ...
The US Food and Drug Administration (FDA) has cleared Oramed's investigational new drug (IND) application for ORMD-0801, an oral insulin capsule, allowing the company to begin clinical trials of the drug. ORMD-0801 is an orally ingestible ...
Tags: FDA, Oral Insulin Capsule
Sanofi and Regeneron Pharmaceuticals have announced the commencement of patient enrollment in two Phase 3 rheumatoid arthritis (RA) trials, the COMPARE and ASCERTAIN trials, with Sarilumab. The first fully human monoclonal antibody ...
Galapagos and AbbVie have extended their GLPG0634 clinical development collaboration to include Crohn's disease. As per the extension agreement, Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to ...
Tags: AbbVie, Galapagos, Crohn's Disease
Cempra, a clinical-stage pharmaceutical company, has signed an exclusive license and development agreement for solithromycin with Toyama Chemical, a subsidiary of Fujifilm Holdings in Japan. As per the terms of the license and development ...
Tags: Cempra, Toyama Chemical, pharmaceutical